Anna Permyakova

681 total citations
13 papers, 177 citations indexed

About

Anna Permyakova is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Anna Permyakova has authored 13 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Anna Permyakova's work include Diet and metabolism studies (6 papers), Cannabis and Cannabinoid Research (5 papers) and Pancreatic function and diabetes (5 papers). Anna Permyakova is often cited by papers focused on Diet and metabolism studies (6 papers), Cannabis and Cannabinoid Research (5 papers) and Pancreatic function and diabetes (5 papers). Anna Permyakova collaborates with scholars based in Israel, United States and Germany. Anna Permyakova's co-authors include Joseph Tam, Alina Nemirovski, Shiran Udi, Rivka Hadar, Adi Drori, Liad Hinden, Saja Baraghithy, Gil Leibowitz, Merav Cohen and Yaakov Nahmias and has published in prestigious journals such as Nature Communications, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Anna Permyakova

12 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Permyakova Israel	8	73	60	44	41	40	13	177
Maja Baretić Croatia	10	28 0.4×	51 0.8×	123 2.8×	34 0.8×	40 1.0×	42	255
Zahir Hussain Japan	10	152 2.1×	99 1.6×	79 1.8×	77 1.9×	54 1.4×	21	328
Deon Doree United States	9	53 0.7×	171 2.9×	208 4.7×	120 2.9×	33 0.8×	11	314
Elena Theophilidou United Kingdom	6	164 2.2×	57 0.9×	56 1.3×	39 1.0×	45 1.1×	7	244
Qinghu He China	13	33 0.5×	15 0.3×	21 0.5×	146 3.6×	30 0.8×	43	324
Mahtab Niyyati United States	7	12 0.2×	33 0.6×	38 0.9×	90 2.2×	44 1.1×	12	265
Raquel Sirvente Brazil	11	18 0.2×	26 0.4×	91 2.1×	74 1.8×	39 1.0×	14	297
J Oliván Spain	8	14 0.2×	65 1.1×	68 1.5×	36 0.9×	41 1.0×	13	241
Binod Timalsina South Korea	7	25 0.3×	20 0.3×	16 0.4×	46 1.1×	12 0.3×	21	147

Countries citing papers authored by Anna Permyakova

Since Specialization

Citations

This map shows the geographic impact of Anna Permyakova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Permyakova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Permyakova more than expected).

Fields of papers citing papers by Anna Permyakova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Permyakova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Permyakova. The network helps show where Anna Permyakova may publish in the future.

Co-authorship network of co-authors of Anna Permyakova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Permyakova. A scholar is included among the top collaborators of Anna Permyakova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Permyakova. Anna Permyakova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Permyakova, Anna, Saja Baraghithy, Narottam Prasad Sahu, et al.. (2025). Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions. Molecular Metabolism. 98. 102192–102192.

Cohen‐Daniel, Leonor, Oded Shamriz, Amijai Saragovi, et al.. (2025). Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in mice. Nature Communications. 16(1). 4292–4292. 2 indexed citations

Permyakova, Anna, Liad Hinden, Saja Baraghithy, et al.. (2024). Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD. Journal of the American Society of Nephrology. 35(3). 281–298. 9 indexed citations

Permyakova, Anna, et al.. (2023). Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans. International Journal of Molecular Sciences. 24(17). 13636–13636. 7 indexed citations

Hinden, Liad, Saja Baraghithy, Anna Permyakova, et al.. (2022). Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes. Journal of Controlled Release. 353. 254–269. 10 indexed citations

Permyakova, Anna, et al.. (2022). MO067: Role of ANT2 in the Development of Obesity-Induced Chronic Kidney Disease. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations

Permyakova, Anna, et al.. (2022). The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity. International Journal of Molecular Sciences. 23(10). 5610–5610. 9 indexed citations

Abu‐Gazala, Samir, Michael Bergel, Aaron B. Baker, et al.. (2022). Generation and characterization of a mouse model for one anastomosis gastric bypass surgery. American Journal of Physiology-Endocrinology and Metabolism. 322(5). E414–E424. 3 indexed citations

Drori, Elyashiv, et al.. (2021). Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. The Journal of Nutritional Biochemistry. 98. 108867–108867. 13 indexed citations

10.

Schyr, Rachel Ben‐Haroush, Abbas Al‐Kurd, Anna Permyakova, et al.. (2021). Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss. Diabetes. 70(10). 2289–2298. 18 indexed citations

11.

Permyakova, Anna, et al.. (2020). A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities. Frontiers in Endocrinology. 11. 91–91. 8 indexed citations

12.

Drori, Adi, Anna Permyakova, Rivka Hadar, et al.. (2018). Cannabinoid‐1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells. Diabetes Obesity and Metabolism. 21(1). 146–159. 32 indexed citations

13.

Hinden, Liad, Shiran Udi, Adi Drori, et al.. (2017). Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy. Journal of the American Society of Nephrology. 29(2). 434–448. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact